特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 2月2日，中国人民政治协商会议上海市第十四届委员会第四次会议世博中心开幕。 摘要 ： 2月2日，上海市政协十四届四次会议开幕。委员杨曙光关注"两重两新"建设，强调科学仪器国产 化对上海建设全球科创中心的重要性，正调研该领域，助力提升科技自主创新能力。 会前，市政协委员杨曙光告诉记者，他今年重点关注"两重两新"建设，认为这是"十五五"规划 中推动基础设施改善、带动消费增长的重要举措。 谈 及 对 上 海 建 设 全 球 科 技 创 新 中 心 的 期 待 时 ， 他 特 别 强 调 科 学 仪 器 国 产 化 的 紧 迫 性 。 他 指 出："科学仪器是'科学的眼睛'，是开展科研工作不可或缺的工具。我目前正围绕这一领域展 开调研，希望能为推动国产科学仪器发展、提升科技自主创新能力，贡献自己的一份力量。" | 版 权 ： 本 文 部 分 素 材 源 自 网 络 ， 版 权 归 原 作 者 所 有 ， 观 点 代 表 作 者 本 人 ， 不 代 表 本 号 立 场 发 文 不 易 ， 请 帮 编 ...

Investment Rating - The report assigns a "Buy" rating for the company, HaiNeng Technology (920476) [1]. Core Insights - HaiNeng Technology is focusing on the scientific instrument sector, leveraging both self-research and acquisitions to build a diverse product matrix, benefiting from the increasing domestic market share in scientific instruments [3][9]. - The company has established a strong competitive barrier through a full industry chain model, ensuring stable cash flow from its core products while expanding into high-growth areas such as chromatography instruments [3][10]. - The global market for analytical instruments is projected to grow significantly, with China's market expected to reach $11.66 billion by 2029, driven by increasing demand across various sectors [9][53]. Summary by Sections Company Overview - HaiNeng Technology, founded in 2006, specializes in the research, production, and sales of analytical instruments, initially focusing on Kjeldahl nitrogen analyzers and microwave digestion instruments, and later expanding into chromatography instruments [15]. - The company has developed a product matrix that includes organic element analysis, sample preparation, chromatography, and general instruments, serving various industries such as food, pharmaceuticals, and environmental testing [15][9]. Market Potential - The analytical instrument market is characterized by high technical barriers and diverse applications, with significant growth expected in the Chinese market, which is projected to grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2029 [53][50]. - The demand for analytical instruments is widespread across sectors, including food safety, pharmaceuticals, and environmental monitoring, indicating a robust market potential [50][53]. Financial Performance - The company is expected to see a recovery in performance, with projected revenues of 3.79 billion yuan in 2025, reflecting a 22.25% year-on-year growth, and net profits expected to reach 420 million yuan [1][10]. - The earnings per share (EPS) are forecasted to improve from 0.15 yuan in 2024 to 0.49 yuan in 2025, indicating a positive trend in profitability [1][10]. Competitive Landscape - The Chinese analytical instrument market is currently dominated by foreign brands, with a high import rate for advanced products. However, domestic manufacturers like HaiNeng Technology are gradually gaining market share by offering competitive pricing and tailored services [9][58]. - The report highlights the importance of innovation and quality improvement in enhancing the competitive position of domestic firms in the analytical instrument sector [9][58].

Investment Rating - The report assigns a "Buy" rating for the company, HaiNeng Technology (920476) [1]. Core Insights - HaiNeng Technology has established a multi-product matrix through self-research and acquisitions, benefiting from the growth in the scientific instrument sector and increasing domestic market share [3][9]. - The company is focusing on a full industry chain model, which enhances its competitive barriers and ensures stable cash flow from its core products [3][9]. - The market for experimental analysis instruments is expected to grow significantly, with the Chinese market projected to reach $11.66 billion by 2029, driven by increasing domestic demand and a shift towards local production [9][53]. Summary by Sections 1. Company Overview - HaiNeng Technology, founded in 2006, specializes in the research, production, and sales of experimental analysis instruments, initially focusing on Kjeldahl nitrogen analyzers and microwave digestion instruments, and later expanding into chromatography instruments [15]. - The company has developed a diverse product range, including organic element analysis, sample preparation, chromatography, and general instruments, serving various sectors such as food, pharmaceuticals, and environmental testing [15]. 2. Market Potential - The global market for experimental analysis instruments is expected to grow from $82.95 billion in 2024 to $101.58 billion by 2029, with a compound annual growth rate (CAGR) of 4.10% [53][55]. - The Chinese market is anticipated to grow from $9.28 billion in 2024 to $11.66 billion by 2029, with a CAGR of 4.7% [53][55]. 3. Business Strategy - The company employs a multi-brand and multi-product strategy, focusing on high-value and technology-intensive products, particularly in the chromatography sector, which has shown significant growth potential [9][25]. - HaiNeng Technology has made strategic acquisitions to enhance its product offerings and market reach, including investments in companies that possess core technologies [9][15]. 4. Financial Projections - The company is projected to achieve total revenue of 3.79 billion yuan in 2025, with a net profit of 420 million yuan, reflecting a significant recovery in performance driven by increased demand in the pharmaceutical and renewable energy sectors [1][10]. - The earnings per share (EPS) is expected to rise from 0.15 yuan in 2024 to 0.49 yuan in 2025, indicating a strong rebound in profitability [1][10]. 5. Competitive Landscape - The experimental analysis instrument market is characterized by high barriers to entry, with significant competition from established international players, while domestic manufacturers are gradually increasing their market share through improved product quality and customer service [9][58].

Group 1 - Konomei (Beijing) Technology Co., Ltd. has completed several million yuan A+ round financing, led by Jiuan Medical, to accelerate commercialization and continue independent research and innovation [1] - The company, founded in 2019, focuses on the independent research and industrialization of ultra-high performance liquid chromatography (UHPLC) technology, with the core founding team having an average of nearly 20 years of experience in the life science instrument field [1] - As of April 2025, Konomei has applied for over 30 patents and software copyrights, including 6 invention patents and 14 utility model patents, along with multiple proprietary technologies [1] Group 2 - Jiuan Medical's chairman, Liu Yi, emphasizes the company's commitment to discovering and partnering with practical enterprises that can address industry pain points and lead industrial upgrades [2] - Jiuan Medical focuses on two core opportunities: deepening independent research around the "Stanford model" to activate the "engineer dividend" and seizing the wave of domestic scientific instrument production and policy support to promote import substitution in the global market [2] - Konomei's breakthroughs in the ultra-high performance liquid chromatography field have disrupted China's long-standing reliance on imports in the high-end market of this sector [2]

Core Viewpoint - The article highlights the significant advancements and growth of Konomai (Beijing) Technology Co., Ltd. in the high-end scientific instrument sector, particularly in the field of ultra-high-performance liquid chromatography (UHPLC), emphasizing its role in the domestic market's shift towards self-sufficiency and reduced reliance on imports [2][5]. Group 1: Company Overview - Konomai has completed a multi-million A+ round of financing led by Jiuan Medical, with funds aimed at accelerating commercialization and continuous innovation in independent research and development [2]. - Founded in 2019, Konomai focuses on the independent research and industrialization of UHPLC technology, with its core founding team averaging nearly 20 years of experience in the life science instrument field [2]. - The company has applied for over 30 patents and software copyrights, including 6 invention patents and 14 utility model patents, as of April 2025 [2]. Group 2: Product and Market Position - Konomai has achieved a 95% localization rate for its product components, significantly contributing to the reduction of procurement costs and enhancing analysis efficiency for clients [3]. - The company has launched a full series of UHPLC products, including automated IVD two-dimensional liquid chromatography systems and intelligent chromatography data management systems [2]. - Since initiating its commercialization strategy in 2023, Konomai has experienced a sales growth rate exceeding 50% annually, with international market growth surpassing 80% [3][4]. Group 3: Investment Perspective - Jiuan Medical's chairman, Liu Yi, emphasizes the importance of collaborating with practical enterprises that can address industry pain points and lead industrial upgrades, focusing on self-research and the domestic scientific instrument market [5]. - Konomai's advancements in the UHPLC sector are seen as pivotal in breaking the long-standing reliance on imports in China's high-end market [5].

Core Viewpoint - Suzhou Langsheng Scientific Instrument Co., Ltd. has emerged as a significant player in the field of spectroscopic instruments through technological innovation, starting with handheld X-ray fluorescence spectrometers and expanding into various portable analytical instruments widely used in environmental protection, petrochemicals, and scientific research, thereby promoting the development of domestic scientific instruments [2][5]. Group 1: Company Development - Founded in 2012, Langsheng initially targeted the market with handheld X-ray fluorescence spectrometers (XRF) amidst a landscape dominated by international giants [5]. - The company adopted a "low-key and pragmatic" craftsmanship spirit, focusing on breakthroughs in specific scenarios due to the technological gap in core algorithms and detectors in domestic instruments [5]. - In 2014, Langsheng developed the Super-FP algorithm, enhancing the precision of XRF quantitative analysis with advanced mathematical models [5]. - The year 2018 marked the launch of a portable oil analysis instrument that quickly and accurately detects sulfur content in oil, gaining widespread recognition in the maritime system [5][6]. Group 2: Technological Innovations - In 2021, Langsheng introduced the first domestic portable X-ray diffraction instrument, "YingSHINE," filling a gap in the domestic market and enhancing its technical advantages in X-ray crystallography [6]. - The company is set to launch the first domestic portable total reflection X-ray fluorescence spectrometer (TXRF) in 2024, marking a significant breakthrough in trace element analysis technology [6]. - Over the years, Langsheng has developed multiple products, including portable X-ray fluorescence-Raman combined instruments and desktop X-ray diffraction instruments, which have received nominations for industry awards, reflecting their trust and recognition in the scientific instrument sector [6][13]. Group 3: Strategic Transition - Langsheng is transitioning from a device manufacturer to a multi-technology platform solution provider, driven by continuous technological investment and team expansion, with the team size exceeding 100 by 2025 [13]. - The company has adopted a differentiated path of "scene-defined technology" rather than merely pursuing parameter replacement, focusing on specific application areas such as metal materials, environmental protection, and petrochemicals [14]. - Langsheng's technological achievements have been deeply integrated into environmental law enforcement, industrial quality control, and scientific innovation, continuously driving improvements in detection efficiency [14].

Core Viewpoint - The article discusses the recent institutional research conducted on Steel Research Nake, highlighting its national testing base layout, service coverage capabilities, advantages in instrument business, growth drivers for testing and instrument sectors, and shareholder return policies [1][2]. Company Overview - Steel Research Nake is an innovative enterprise specializing in the research, development, and application of metal material testing technology. The company offers services including testing services, analytical instruments, standard materials, capability verification services, corrosion protection engineering, and other extended testing services. Its applications span various industries such as steel, metallurgy, aerospace, nuclear power, and food [3]. Financial Performance - As of 2024, the company achieved a revenue of 1,097.67 million yuan, a year-on-year increase of 15.60%. The net profit attributable to shareholders was 145.02 million yuan, up 15.37% year-on-year. Basic earnings per share were 0.3861 yuan, reflecting a 15.25% increase. By March 31, 2025, the revenue reached 219.06 million yuan, a 7.18% increase year-on-year, with a net profit of 16.08 million yuan, up 33.28% year-on-year, and basic earnings per share of 0.0428 yuan, a 32.10% increase [4]. Testing Base Layout - The company has strategically laid out national testing bases in cities such as Beijing, Kunshan, Chengdu, Shenyang, Qingdao, Xi'an, Zhuozhou, and Zhuzhou, effectively meeting customer needs based on their distribution characteristics [5]. Instrument Business Advantages - The company’s instrument products cover over 60 types across eight categories, including atomic emission spectroscopy, mass spectrometry, gas analysis, and mechanical performance testing. Notable products include the spark direct reading spectrometer, which has won national awards, and the company leads in sales within the industry [6]. Market Opportunities - The domestic instrument industry is experiencing significant growth potential, driven by complex international conditions that accelerate the domestic replacement process, providing more opportunities for local scientific instrument manufacturers [7]. Future Development Directions - The company aims to enhance its testing and instrument businesses by exploring additional testing needs beyond metal materials, improving management efficiency, and increasing automation. In the instrument sector, the focus will be on improving product quality and expanding market share in high-end scientific instruments [8]. Growth Drivers - The growth of the company is supported by the rapid development of new materials in China and increasing demand for testing in key sectors such as aerospace and nuclear power. The scientific instrument sector is also benefiting from favorable policies, leading to accelerated domestic production [9]. Business Focus Areas - The company is focusing its testing business on high-demand areas such as aerospace and nuclear power, while also expanding into other material testing sectors, maintaining its competitive edge in metal material testing [10]. Shareholder Return Policy - The company emphasizes market value management and shareholder returns, maintaining a cash dividend policy where the proportion of cash dividends to net profit has consistently exceeded 30% in recent years [11].